ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
Paradigm Phase 2 Ross River Virus Clinical Trial Update
Published: 14/09/17, 09:29am (AEST)•2 pages